Expression of JAM-A in the Human Corneal Endothelium and Retinal Pigment Epithelium: Localization and Evidence for Role in Barrier Function
- 1 September 2007
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 48 (9) , 3928-3936
- https://doi.org/10.1167/iovs.06-1536
Abstract
Purpose. Junctional adhesion molecules (JAMs) are a family of adhesion proteins found in intercellular junctions. Evidence suggests that JAM-A is important for the regulation of tight junction assembly and epithelial barrier function. The authors recently reported that JAM-A is expressed in rabbit corneal endothelium and that antibody to JAM-A produces corneal swelling. In the present study, they investigate JAM-A expression in the human corneal endothelium and retinal pigment epithelium (RPE) and examine the effect of a function-blocking antibody to JAM-A on the permeability of cultured RPE cell monolayers. methods. Expression of JAM-A in human corneal endothelium, human RPE tissue, and cultured ARPE-19 monolayers was assessed by immunofluorescence confocal microscopy. Localization of JAM-A was compared with the tight junction-associated protein zonula occludens-1 (ZO-1). To investigate JAM-A function in ARPE-19 cells, ARPE-19 monolayers were subjected to a calcium switch protocol to disrupt cell junctions and treated with a function-blocking antibody to JAM-A or an isotype-matched control. Dextran flux assays were performed to assess the effect of JAM-A antibody on ARPE-19 monolayer permeability. results. Expression of JAM-A was observed in human corneal endothelium, and its distribution correlated with the tight junction-associated protein ZO-1. In addition, expression of JAM-A was observed in human RPE and in intercellular junctions of ARPE-19 monolayers. The localization pattern of JAM-A in the RPE and ARPE-19 monolayers was similar to that of ZO-1. ARPE-19 monolayers treated with antibody to JAM-A demonstrated a 33% increase in permeability to 10,000 MWt dextran compared with monolayers treated with control antibody. conclusions. Results of this study provide new information about JAM-A expression in tight junctions of the human corneal endothelium and human RPE. The observation that antibodies to JAM-A increase ARPE-19 monolayer permeability is consistent with previous findings of JAM-A function in epithelial tight junctions and suggests JAM-A may have a role in the regulation of RPE barrier function.Keywords
This publication has 39 references indexed in Scilit:
- Deletion of JAM-A causes morphological defects in the corneal epitheliumThe International Journal of Biochemistry & Cell Biology, 2007
- X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motifThe EMBO Journal, 2001
- Junctional adhesion molecule (JAM) binds to PAR-3The Journal of cell biology, 2001
- The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM)The EMBO Journal, 2001
- Association of Junctional Adhesion Molecule with Calcium/calmodulin-dependent Serine Protein Kinase (CASK/LIN-2) in Human Epithelial Caco-2 CellsPublished by Elsevier ,2001
- Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulationAmerican Journal of Physiology-Cell Physiology, 2000
- Homophilic Interaction of Junctional Adhesion MoleculeJournal of Biological Chemistry, 2000
- Junctional Adhesion Molecule Interacts with the PDZ Domain-containing Proteins AF-6 and ZO-1Journal of Biological Chemistry, 2000
- The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilinProceedings of the National Academy of Sciences, 2000
- The Resiliency of the Corneal Endothelium to Refractive and Intraocular SurgeryCornea, 2000